In light of new national guidelines by the AHA/ACC that recommend lifestyle intervention as the primary mode of treatment for adults with hypertension (HTN), we assessed weight loss achieved by adults that had a HTN diagnosis and/or a measured blood pressure (BP) ≥140/90 mm Hg in an intensive lifestyle change intervention provided by lifestyle coaches using the National Diabetes Prevention Program (DPP) curriculum. From 2008-2016, 6,418 participants enrolled in the Montana DPP, and 55.8% (n=3,582) had HTN/BP on enrollment. Participants with HTN/BP were significantly older, weighed more at baseline, had greater fasting glucose, and attended more sessions than did other participants (Table). After the 16-week core sessions four months), participants in both groups achieved significant weight loss. Results from the logistic regression model indicated that the factors independently associated with achieving 7% weight loss were being female [AOR 0.57, 95% 0.44-0.74], having low prediabetes risk score of 3-8 [AOR 0.60, 95% 0.40-0.89], meeting the physical activity goal [AOR 1.46, 95% 1.17-1.82], and self-monitoring fat for 7-13 weeks [AOR 5.66, 95% 4.10-7.81] and 14-16 weeks [AOR 12.81, 95% 8.87-18.49]. These data suggest, the DPP is likely an effective method to support adults with HTN/BP in making recommended lifestyle changes and decreasing an important blood pressure risk.
Table. Participant baseline characteristics and outcomes during the 16-week core (four months), by hypertension/BP status, Montana DPP, 2008-2016.
Hypertension/BP ≥140/90 (N = 3,582) | No Hypertension/BP <140/90 (N = 2,828) | |
Mean (SD) | Mean (SD) | |
Age (Years) | 55.8 (11.6) | 51.2 (12.5)* |
Baseline BMI (kg/m2) | 37.1 (7.3) | 35.2 (7.0)* |
Baseline fasting blood glucose (mg/dL) | 101.4 (13.7) | 98.5 (13.3) |
Sessions attended | 15.0 (6.1) | 14.7 (6.0)* |
Weight change (kg) | -5.1 (5.3) | -4.8 (5.3)* |
% (n) | % (n) | |
Sex (Female) | 79.1 (2,836) | 85.2 (2,406)* |
Prediabetes risk score (low 3-8) | 7.9 (108) | 12.7 (109) |
Met ≥150 min/week physical activity goal | 58.3 (1,867) | 57.7 (1,449) |
Self-monitored fat intake 14-16 weeks | 30.8 (1,015) | 26.0 (659)* |
Achieved ≥5% weight loss | 47.4 (1,701) | 46.0 (1,300) |
Achieved ≥7% weight loss goal | 31.7 (1,138) | 30.0 (848) |
*P≤0.05 |
Hypertension/BP ≥140/90 (N = 3,582) | No Hypertension/BP <140/90 (N = 2,828) | |
Mean (SD) | Mean (SD) | |
Age (Years) | 55.8 (11.6) | 51.2 (12.5)* |
Baseline BMI (kg/m2) | 37.1 (7.3) | 35.2 (7.0)* |
Baseline fasting blood glucose (mg/dL) | 101.4 (13.7) | 98.5 (13.3) |
Sessions attended | 15.0 (6.1) | 14.7 (6.0)* |
Weight change (kg) | -5.1 (5.3) | -4.8 (5.3)* |
% (n) | % (n) | |
Sex (Female) | 79.1 (2,836) | 85.2 (2,406)* |
Prediabetes risk score (low 3-8) | 7.9 (108) | 12.7 (109) |
Met ≥150 min/week physical activity goal | 58.3 (1,867) | 57.7 (1,449) |
Self-monitored fat intake 14-16 weeks | 30.8 (1,015) | 26.0 (659)* |
Achieved ≥5% weight loss | 47.4 (1,701) | 46.0 (1,300) |
Achieved ≥7% weight loss goal | 31.7 (1,138) | 30.0 (848) |
*P≤0.05 |
S.M. Brokaw: None. D. Carpenedo: None. S. Tysk: None. J. Fernandes: None. S.D. Helgerson: None. T.S. Harwell: None.